Specialized Manufacturing Coldstream Laboratories offers highly specialized aseptic and non-aseptic drug product manufacturing with mobile isolator technology, providing a unique solution for companies developing potent, cytotoxic, or radiolabeled compounds seeking secure containment and sterile facility services.

Growth and Acquisition History Having been acquired by Piramal Pharma Solutions in 2015 for approximately 30 million dollars, Coldstream has demonstrated strong strategic interest from large pharmaceutical groups, indicating potential for expanding service partnerships and collaborative opportunities.

Market Niche Opportunity Positioned within the pharmaceutical manufacturing sector focused on parenteral drug development, Coldstream serves a niche market that includes firms requiring rapid, flexible sterile manufacturing solutions, ideal for companies needing custom and scalable production capabilities.

Revenue Range and Potential With an estimated revenue between 25 million and 50 million dollars and a relatively modest employee base, Coldstream presents an attractive target for companies seeking reliable outsourcing in specialized drug production without the complexity of large enterprise competition.

Technological Engagement Utilizing advanced technology like React, HubSpot, and micro testing systems, Coldstream indicates openness to modern digital tools and partnerships that could streamline communication, project management, and quality assurance processes in outsourced manufacturing activities.